SELENBP1 and Cognitive impairment: To our knowledge it is the only study that has reported direct evidence of SELENBP1 involvement in ALS, nevertheless Glatt, S.J., et al. reported SELENBP1 expression to be significantly up-regulated in post-mortem brain tissue from patients with schizophrenia and cognitive impairment [53].